JP2005525302A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525302A5
JP2005525302A5 JP2003545691A JP2003545691A JP2005525302A5 JP 2005525302 A5 JP2005525302 A5 JP 2005525302A5 JP 2003545691 A JP2003545691 A JP 2003545691A JP 2003545691 A JP2003545691 A JP 2003545691A JP 2005525302 A5 JP2005525302 A5 JP 2005525302A5
Authority
JP
Japan
Prior art keywords
conjugate
poly
ethylene glycol
growth
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003545691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/037270 external-priority patent/WO2003044056A2/en
Publication of JP2005525302A publication Critical patent/JP2005525302A/ja
Publication of JP2005525302A5 publication Critical patent/JP2005525302A5/ja
Pending legal-status Critical Current

Links

JP2003545691A 2001-11-20 2002-11-20 化学的に修飾されたヒト成長ホルモンコンジュゲート Pending JP2005525302A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33190701P 2001-11-20 2001-11-20
PCT/US2002/037270 WO2003044056A2 (en) 2001-11-20 2002-11-20 Chemically-modified human growth hormone conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006193577A Division JP2006321808A (ja) 2001-11-20 2006-07-14 化学的に修飾されたヒト成長ホルモンコンジュゲート

Publications (2)

Publication Number Publication Date
JP2005525302A JP2005525302A (ja) 2005-08-25
JP2005525302A5 true JP2005525302A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23295870

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003545691A Pending JP2005525302A (ja) 2001-11-20 2002-11-20 化学的に修飾されたヒト成長ホルモンコンジュゲート
JP2006193577A Pending JP2006321808A (ja) 2001-11-20 2006-07-14 化学的に修飾されたヒト成長ホルモンコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006193577A Pending JP2006321808A (ja) 2001-11-20 2006-07-14 化学的に修飾されたヒト成長ホルモンコンジュゲート

Country Status (25)

Country Link
EP (1) EP1453859A2 (cg-RX-API-DMAC7.html)
JP (2) JP2005525302A (cg-RX-API-DMAC7.html)
KR (2) KR20070072924A (cg-RX-API-DMAC7.html)
CN (1) CN1608079A (cg-RX-API-DMAC7.html)
AP (1) AP2004003050A0 (cg-RX-API-DMAC7.html)
AU (1) AU2002356990A1 (cg-RX-API-DMAC7.html)
BR (1) BR0214451A (cg-RX-API-DMAC7.html)
CA (1) CA2467731A1 (cg-RX-API-DMAC7.html)
CO (1) CO5580794A2 (cg-RX-API-DMAC7.html)
EA (2) EA200700431A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP045114A (cg-RX-API-DMAC7.html)
GE (1) GEP20063860B (cg-RX-API-DMAC7.html)
HR (1) HRP20040448A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0500997A2 (cg-RX-API-DMAC7.html)
IL (1) IL162031A0 (cg-RX-API-DMAC7.html)
IS (1) IS7268A (cg-RX-API-DMAC7.html)
MA (1) MA27544A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04004809A (cg-RX-API-DMAC7.html)
NO (1) NO20042182L (cg-RX-API-DMAC7.html)
OA (1) OA13063A (cg-RX-API-DMAC7.html)
PL (1) PL374354A1 (cg-RX-API-DMAC7.html)
RS (1) RS53104A (cg-RX-API-DMAC7.html)
TN (1) TNSN04090A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003044056A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200403907B (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
US6916962B2 (en) 2001-12-11 2005-07-12 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
US6956135B2 (en) 2001-12-11 2005-10-18 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
EP1507755A4 (en) * 2001-12-11 2006-05-17 Sun Bio Inc NOVEL MONOFUNCTIONAL POLYETHYLENE GLYCOL ALDEHYDES
US7041855B2 (en) 2001-12-11 2006-05-09 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
PT3025726T (pt) * 2002-01-18 2020-01-09 Biogen Ma Inc Compostos do polímero polialquileno e utilizações dos mesmos
JP4764630B2 (ja) 2002-09-09 2011-09-07 ネクター セラピューティックス 水溶性ポリマーアルカナール
EP1591467A1 (en) * 2002-09-09 2005-11-02 Nektar Therapeutics Al, Corporation Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone
US20040142870A1 (en) * 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
US20050281778A1 (en) * 2003-03-28 2005-12-22 Myung-Ok Park Human growth hormone conjugated with biocompatible polymer
WO2005035553A2 (en) * 2003-10-10 2005-04-21 Novo Nordisk A/S Conjugation of peptides
US7524813B2 (en) 2003-10-10 2009-04-28 Novo Nordisk Health Care Ag Selectively conjugated peptides and methods of making the same
EP2033662B1 (en) * 2004-01-21 2012-10-17 Novo Nordisk Health Care AG Transglutaminase mediated conjugation of peptides
AU2005278903A1 (en) * 2004-08-31 2006-03-09 Pharmacia & Upjohn Company Llc Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof
CA2594557C (en) * 2004-12-22 2016-04-26 Ambrx, Inc. Modified human growth hormone
NZ555308A (en) 2004-12-22 2010-10-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
JP2008525032A (ja) * 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド 組換えヒト成長ホルモンを発現及び精製するための方法
WO2006084888A2 (en) 2005-02-10 2006-08-17 Novo Nordisk A/S C-terminally pegylated growth hormones
AU2006237329B2 (en) 2005-04-18 2012-04-12 Novo Nordisk A/S IL-21 variants
US8293708B2 (en) 2005-08-30 2012-10-23 Novo Nordisk Health Care A/G Liquid formulations N-terminal serine of pegylated growth hormone
HRP20110404T1 (hr) * 2005-11-08 2011-08-31 Ambrx Ubrzivači za modifikaciju ne-prirodnih aminokiselina i polipeptida ne-prirodnih aminokiselina
KR101423898B1 (ko) 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
WO2008003750A2 (en) * 2006-07-07 2008-01-10 Novo Nordisk Health Care Ag New protein conjugates and methods for their preparation
CN101108895B (zh) * 2006-07-19 2011-10-26 北京键凯科技有限公司 聚乙二醇乙醛衍生物及其与药物的结合物
AU2007310777A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S IL-21 variants
CL2008002399A1 (es) * 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
JP5458416B2 (ja) * 2008-04-03 2014-04-02 バイオスティード ジーン エクスプレッション テック. カンパニー リミテッド 二本鎖ポリエチレングリコール化成長ホルモン、その製造方法およびその使用
CA3004716C (en) 2008-04-29 2022-04-12 Ascendis Pharma Endocrinology Division A/S Pegylated recombinant human growth hormone compounds
KR101104574B1 (ko) * 2008-05-14 2012-01-11 성균관대학교산학협력단 폴리에틸렌글리콜로 화학적으로 수식된 인간 성장 호르몬, 이의 제조방법 및 용도
JP5639585B2 (ja) * 2008-07-31 2014-12-10 ファーマエッセンティア コーポレイション ペプチド−ポリマー共役体
WO2010015668A1 (en) 2008-08-06 2010-02-11 Novo Nordisk A/S Conjugated proteins with prolonged in vivo efficacy
RU2409669C9 (ru) * 2008-08-18 2012-05-27 ООО "Саентифик Фьючер Менеджмент" ("Scientific Future Management", "SFM") Способ иммобилизации биологически активного вещества (бав) на носитель (варианты) и конъюгат бав-носитель, полученный данными способами
EP2331139B1 (en) * 2008-09-11 2019-04-17 Nektar Therapeutics Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
WO2011015649A1 (en) 2009-08-06 2011-02-10 Novo Nordisk Health Care Ag Growth hormones with prolonged in-vivo efficacy
EP2512450B1 (en) 2009-12-15 2018-02-07 Ascendis Pharma Endocrinology Division A/S Dry growth hormone composition transiently linked to a polymer carrier
PL2525834T3 (pl) 2010-01-22 2020-10-19 Novo Nordisk Health Care Ag Hormony wzrostu o przedłużonej skuteczności in-vivo
RU2012134974A (ru) 2010-01-22 2014-02-27 Ново Нордиск Хелс Кеа Аг Стабилизированное соединение гормона роста
JP2013533217A (ja) * 2010-05-17 2013-08-22 セビックス・インコーポレイテッド Peg化c−ペプチド
EP2446898A1 (en) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Use of growth hormone to enhance the immune response in immunosuppressed patients
EA019967B1 (ru) * 2011-12-21 2014-07-30 Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") Ковалентный конъюгат полиэтиленгликоля с гормоном роста человека
ES2841123T3 (es) 2013-04-05 2021-07-07 Formulacion Del Compuesto De La Hormona De Crecimiento Formulación del compuesto de la hormona de crecimiento
AU2015342908B2 (en) 2014-11-06 2021-06-24 Pharmaessentia Corporation Dosage regimen for pegylated interferon
KR102608645B1 (ko) 2014-11-18 2023-12-01 아센디스 파마 엔도크리놀로지 디비전 에이/에스 신규한 중합체성 hGH 프로드러그
EP4732848A3 (en) 2014-11-21 2026-07-29 Ascendis Pharma Endocrinology Division A/S Long-acting growth hormone dosage forms
IL254389B2 (en) * 2015-03-11 2023-03-01 Nektar Therapeutics Polymer conjugates and the il–7 group
KR102152437B1 (ko) 2015-09-18 2020-09-07 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 장시간 작용형 아드레노메둘린 유도체
JP7524206B2 (ja) 2019-03-04 2024-07-29 アセンディス ファーマ エンドクライノロジー ディヴィジョン エー/エス 1日ごとのソマトロピンよりも優れた効力を有する長時間作用性成長ホルモン剤形
CN114539384B (zh) * 2020-11-19 2024-09-06 江苏众红生物工程创药研究院有限公司 聚乙二醇化长效生长激素及其制备方法和医药应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
ES2113354T3 (es) * 1990-05-04 1998-05-01 American Cyanamid Co Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina.
AU1676992A (en) * 1991-03-18 1992-10-21 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
NZ250375A (en) * 1992-12-09 1995-07-26 Ortho Pharma Corp Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
ATE375363T1 (de) * 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
AU775937B2 (en) * 1999-01-14 2004-08-19 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
WO2000044785A1 (en) * 1999-01-29 2000-08-03 F. Hoffmann-La Roche Ag Gcsf conjugates
WO2001076639A2 (en) * 2000-04-06 2001-10-18 Pharmacia Corporation Chemically-modified myelopoietin conjugates
JP2004524020A (ja) * 2001-01-11 2004-08-12 マキシゲン・エイピーエス 改良された成長ホルモン分子

Similar Documents

Publication Publication Date Title
KR101160611B1 (ko) 폴리(에틸렌 글리콜)로 변형된 펩티드 기재 화합물용 신규 스페이서 부분
EP1626983B1 (en) Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
US20200046725A1 (en) Prodrug Comprising a Drug Linker Conjugate
JP2514950B2 (ja) 化学修飾蛋白質,その製造法および中間体
CA2176229C (en) Improved interferon polymer conjugates
EP1324779B1 (en) Pegylated interleukin-10
EP3243834A1 (en) Site-directed modification of fviii
RU2006128293A (ru) Коньюгаты гормона роста человека, монопэгилированного по n-концу, способ их получения и способы их применения
US20090221471A1 (en) Prodrugs of vancomycin with hydrolysis resistant polymer linkages
JP2001523465A5 (cg-RX-API-DMAC7.html)
JP2005527470A5 (cg-RX-API-DMAC7.html)
WO1999038891A1 (en) Multimeric erythropoietin with altered biological activity
JP5657011B2 (ja) カテコールポリエチレングリコール誘導体と蛋白質またはペプチドの接合体、及びこれの製造方法
JP2022545917A5 (cg-RX-API-DMAC7.html)
CN1449412A (zh) Dds化合物及其制备方法
JP2023093634A5 (cg-RX-API-DMAC7.html)
CN1252130C (zh) 亲水性聚合物与丹参酮类药物的结合物以及包含该结合物的药物组合物
KR20220074813A (ko) 비오틴 모이어티, 지방산 모이어티 또는 이의 조합이 결합된 생리활성 물질 접합체
JP2009502779A (ja) 生体適合性ポリマーに結合させたヒト成長ホルモン
TH76940A (th) คอนจูเกตของฮอร์โมนเร่งการเจริญเติบโตของมนุษย์โมโนพิไกเลตที่มีไนโตรเจนปิดท้ายและกรรมวิธีการเตรียมฮอร์โมนชนิดนี้
CN1252045C (zh) 端氨基聚氧乙烯的合成方法
JP2011507487A5 (cg-RX-API-DMAC7.html)
KR100480429B1 (ko) 인터페론-알파와 폴리에틸렌글리콜 유도체의 배합체
WO2005085283A1 (ja) 修飾インターロイキン−11及びそれを含有する医薬組成物
JPS6330499A (ja) オピオイドペプチド・ポリペプチド複合体